Oxford Textbook of Clinical Nephrology

SECTION 1: ASSESSMENT OF THE PATIENT WITH RENAL DISEASE; 1.1 History and clinical examination of the patient with renal disease; 1.2 Urinalysis and microscopy; 1.3 The clinical assessment of renal function; 1.4 Renal function in the newborn infant; 1.5 The aging kidney; 1.6.1 Imaging techniques in nephrology; 1.6.2 Imaging techniques in clinical nephrology; SECTION 2: THE PATIENT WITH FLUID, ELECTROLYTE, AND DIVALENT ION DISORDERS; 2.1 Hypo-hypernatraemia: disorders of water balance; 2.2 Hypo-hyperkalaemia; 2.3 Hypo-hypercalcaemia; 2.4 Hypo-hyperphosphataemia; 2.5 Hypo-hypermagnesaemia; 2.6 Clinical acid-base disorders; SECTION 3: THE PATIENT WITH GLOMERULAR DISEASE; 3.1 The renal glomerulus - the structural basis of ultrafiltration; 3.2 Glomerular injury and glomerular response; 3.3 The patient with proteinuria or haematuria; 3.4 The nephrotic syndrome: Pathophysiology, management, and complications; 3.5 Minimal change and focal segmental glomerular sclerosis; 3.6 IgA nephropathies; 3.7 Membranous nephropathy; 3.8 Mesangiocapillary glomerulonephritis; 3.9 Acute endocapillary glomerulonephritis; 3.10 Crescentic glomerulonephritis; 3.11 Antiglomerular basement disease; 3.12 Infection related glomerulonephritis; 3.13 Malignancy associated glomerular disease; 3.14 Glomerular disease in the tropics; SECTION 4: THE KIDNEY IN SYSTEMIC DISEASE; 4.1 The patient with diabetes mellitus; 4.2 The patient with amyloid or immunotactoid glomerulopathy; 4.3 Kidney involvement in plasma cell dyscrasias; 4.4 The patient with sarcoidosis; 4.5 The patient with vasculitis; 4.6 The patient with mixed cyroglobulinaemia and hepatitis C infection; 4.7 The patient with systemic lupus erythematosus; 4.8 The patient with scleroderma-systemic sclerosis; 4.9 The patient with rheumatoid arthritis, mixed connective tissue disease, or polymyositis; 4.10 The patient with Sjogren's syndrome and overlap syndromes; 4.11 The patient with sickle cell disease; 4.12 The patient exposed to substance misuse, organic solvents and smoking; SECTION 5: THE PATIENT WITH TUBULAR DISEASE; 5.1 The structure and function of tubules; 5.2 Isolated defects of tubular function; 5.3 Fanconi syndrome; 5.4 Renal tubular acidosis; 5.5 Hypokalaemic tubular disorders etc; 5.6 Nephrogenic diabetes insipidus; SECTION 6: THE PATIENT WITH CHRONIC INTERSTITIAL DISEASE; 6.1 Mechanisms of interstitial inflammation; 6.2 Analgesic nephropathy; 6.3 Non-steroidal anti-inflammatory drugs and the kidney; 6.4 Uric acid and the kidney; 6.5 Nephrotoxic metals; 6.6 Radiation nephropathy; 6.7 Balkan nephropathy; 6.8 Chines herbs (and other rare causes of interstitial nephropathy); SECTION 7: THE PATIENT WITH URINARY TRACT INFECTION; 7.1 Lower and upper urinary tract infections in the adult; 7.2 Urinary tract infections in infancy and childhood; 7.3 Renal tuberculosis and other Mycobacterial Infections; 7.4 Schistosomiasis; 7.5 Fungal infections and the kidney; SECTION 8: THE PATIENT WITH RENAL STONE DISEASE; 8.1 Aetiological factors in stone formation; 8.2 The medical management of stone disease; 8.3 The surgical management of renal stones; 8.4 Nephrocalcinosis; 8.5 Renal and urinary tract stone disease in children; SECTION 9: THE PATIENT WITH RENAL HYPERTENSION; 9.1 The structure and function of blood vessels; 9.2 Clinical approach to hypertension; 9.3 The kidney and control of blood pressure; 9.4 The effects of hypertension on renal vasculature and structure; 9.5 Ischaemic nephropathy; 9.6 Hypertension and unilateral renal vasculature and structure; 9.7 Renovascular hypertension; 9.8 Malignant hypertension; 9.9 The hypertensive child; SECTION 10: ACUTE RENAL FAILURE; 10.1 Epidemiology of acute renal failure; 10.2 Aute renal failure: pathophysiology and prevention; 10.3 The clinical approach to the patient with acute renal failure; 10.4 Renal replacement methods in acute renal failure; 10.5 Dialysis and haemoperfusion treatment of acute poisoning; 10.6 Special acute renal failure problems; 10.7 Acute renal failure in a special setting; SECTION 11: THE PATIENT WITH FAILING RENAL FUNCTION; 11.1 Mechanisms of experimental and clinical renal scarring; 11.2 Assessment and initial management of the patient with failing renal function; 11.3 The patient with uraemia; SECTION 12: THE PATIENT ON DIALYSIS; 12.1 Dialysis strategies; 12.2 Vascular access; 12.3 Haemodialysis, haemofiltration and complications of technique; 12.4 Peritoneal dialysis and complications of technique; 12.5 Adequacy of dialysis; 12.6 Medical management of the dialysis patient; 12.7 Psychological aspects of treatment for renal failure; SECTION 13: THE TRANSPLANT PATIENT; 13.1 Selection and preparation of the recipient; 13.2 Transplant immunology; 13.3 Surgery and surgical complications; SECTION 14: SPECIFIC PROBLEMS IN CHRONIC RENAL INSUFFICIENCY; 14.1 Chronic renal failure in children; 14.2 Chronic renal failure in the elderly; 14.3 The diabetic patient with impaired renal function; SECTION 15: THE PREGNANT PATIENT; 15.1 The normal renal physiological changes which occur during pregnancy; 15.2 Renal complications that may occur in pregnancy; 15.3 Pregnancy in patients with underlying renal disease; 15.4 Pregnancy-induced hypertension; SECTION 16: THE PATIENT WITH INHERITED DISEASE; 16.1 Strategies for the investigation of inherited renal disease; 16.2 Cystic diseases; 16.3 Nephronophthisis; 16.4 Inherited glomerular diseases; 16.5 Inherited metabolic diseaes of the kidney; 16.6 Renal involvement in tuberous sclerosis and con Hippel-Lindau disease; 16.7 Some rare syndromes with renal involvement; SECTION 17: THE PATIENT WITH STRUCTURAL AND CONGENITAL ABNORMALITIES; 17.1 The development of the kidney and renal dysplasia; 17.2 Vesicoureteric reflux and reflux nephropathy; 17.3 The patient with urinary tract obstruction; 17.4 Congenital abnormalities of the urinary tract; 17.5 Medullary sponge kidney; SECTION 18: THE PATIENT WITH MALIGNANCY OF THE KIDNEY AND URINARY TRACT; 18.1 Renal carcinoma and other tumours; 18.2 Wilms' tumour; 18.3 Tumours of the renal pelvis and ureter; 18.4 Tumours of the bladder; 18.5 Tumours of the prostate; SECTION 19: PHARMACOLOGY AND DRUG USE IN KIDNEY PATIENTS; 19.1 Drug-induced nephropathies; 19.2 Handling of drugs in kidney disease; 19.3 Action and clinical use of diuretics